2013 Nobel Prize Announcements

BioArctic’s partner Eisai has announced that Leqembi (lecanemab), has been included in the “Commercial Insurance Innovative Drug List”, recently introduced by the National Healthcare Security Administration (NHSA) of China.

Earlier this summer, the European Commission launched a new strategy to make Europe the most attractive place in the world for life sciences by 2030.

MetaCurUm has been awarded SEK 1 million from the Swedish Innovation Agency, Vinnova, under the "Acceleration of Deeptech Companies 2024" initiative.

Mentice has appointed Frans Venker as its new Chief Executive Officer, effective January 1, 2025.

The 11th edition of NLSDays is being held in Malmö on September 18-19. Program Director, Marjo Puumalainen, gives us an inside look into the upcoming conference.

Evaxion Biotech has announced new clinical phase 2 data for its lead compound EVX-01.

Lund University is establishing a university-wide development center for advanced therapies, LU-ATMP. Advanced Therapy Medicinal Products (ATMP) are medicines that are based on cells, tissues or genes. With ATMP, injuries and illnesses can be treated in completely new ways and provide better opportunities to relieve and, to a progressively greater extent, cure a wide range […]